Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-123713
Filing Date
2025-12-19
Accepted
2025-12-19 13:20:30
Documents
3
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0270379-6k_tiziana.htm 6-K 21299
2 TIZIANA LIFE SCIENCES LTD PRESS RELEASE, DATED DECEMBER 19, 2025 ea027037901ex99-1_tiziana.htm EX-99.1 5755
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5770
  Complete submission text file 0001213900-25-123713.txt   36323
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 251586724
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)